New drug could replace opioids for Post-Surgery pain
NCT ID NCT07600697
First seen May 28, 2026 · Last updated Jun 16, 2026 · Updated 4 times
Summary
This study tests a new pain medicine called suzetrigine for women recovering from pelvic surgery. The goal is to see if it controls pain as well as standard opioids but without the risk of addiction or side effects like drowsiness. About 120 women will take either suzetrigine or usual opioid painkillers, and researchers will measure their pain levels and how much opioid rescue medication they need.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PELVIC ORGAN PROLAPSE (POP) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California, Los Angeles (UCLA)
Los Angeles, California, 90095, United States
Conditions
Explore the condition pages connected to this study.